Nagelfar
Bluelight Crew
One (in the same paper, Singh's Cocaine Antagonist one) IC50 value for cocaine has:
DAT w/ [3H]WIN 35428:
249 ± 37
SERT w/ [3H]paroxetine:
615 ± 120
NET w/ [3H]Nisoxetine
2500 ± 70
5-HTT/DAT selectivity
2.5
NET/DAT selectivity
10.0
The other is extremely different; also IC50 values (could it be a typographic error for Ki?):
DAT w/ [3H]WIN 35428:
89 ± 4.8
SERT w/ [3H]paroxetine:
1045 ± 89
NET w/ [3H]Nisoxetine
3298 ± 293
5-HTT/DAT selectivity
11.7
NET/DAT selectivity
37.0
There is no mention of different brain tissues (rat, monkey, etc.) used or other conditions. What could be the variable in these two studies on different tables from the same set of compounds to account for this difference? Even IC50 or Ki values for ligands from different labs seem to be within one point difference from one another; and this is the very same research paper (Page #973 versus #976 (49th versus 52th page of article) Table 28 VS. Table 29)
DAT w/ [3H]WIN 35428:
249 ± 37
SERT w/ [3H]paroxetine:
615 ± 120
NET w/ [3H]Nisoxetine
2500 ± 70
5-HTT/DAT selectivity
2.5
NET/DAT selectivity
10.0
The other is extremely different; also IC50 values (could it be a typographic error for Ki?):
DAT w/ [3H]WIN 35428:
89 ± 4.8
SERT w/ [3H]paroxetine:
1045 ± 89
NET w/ [3H]Nisoxetine
3298 ± 293
5-HTT/DAT selectivity
11.7
NET/DAT selectivity
37.0
There is no mention of different brain tissues (rat, monkey, etc.) used or other conditions. What could be the variable in these two studies on different tables from the same set of compounds to account for this difference? Even IC50 or Ki values for ligands from different labs seem to be within one point difference from one another; and this is the very same research paper (Page #973 versus #976 (49th versus 52th page of article) Table 28 VS. Table 29)
Last edited:
